Pharmacogenomic incidental findings in 308 families: The NIH Undiagnosed Diseases Program experience.

ABSTRACT:

Purpose

Using single-nucleotide polymorphism (SNP) chip and exome sequence data from individuals participating in the National Institutes of Health (NIH) Undiagnosed Diseases Program (UDP), we evaluated the number and therapeutic informativeness of incidental pharmacogenetic variants.

Methods

Pharmacogenomics Knowledgebase (PharmGKB) annotated sequence variants were identified in 1,101 individuals. Medication records of participants were used to identify individuals prescribed medications with a genetic variant that might alter efficacy.

Results

A total of 395 sequence variants, including 19 PharmGKB 1A and 1B variants, were identified in SNP chip sequence data, and 388 variants, including 21 PharmGKB 1A and 1B variants, were identified in the exome sequence data. Nin

SUBMITTER: Lee EM 

PROVIDER: S-EPMC5133159 | biostudies-literature | 2016 Dec

REPOSITORIES: biostudies-literature